These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 461992)

  • 1. Drug metabolism in diabetic isolated perfused rat liver.
    Cook DE; Past MR
    Res Commun Chem Pathol Pharmacol; 1979 May; 24(2):389-92. PubMed ID: 461992
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolism of p-nitroanisole and aniline in isolated hepatocytes of streptozotocin-diabetic rats.
    Eacho PI; Weiner M
    Drug Metab Dispos; 1980; 8(6):385-9. PubMed ID: 6109605
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug metabolism in a reconstituted system by diabetes-dependent hepatic cytochrome P-450.
    Past MR; Cook DE
    Res Commun Chem Pathol Pharmacol; 1982 Jul; 37(1):81-90. PubMed ID: 6812187
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of experimental diabetes on drug metabolism in the rat.
    Ackerman DM; Leibman KC
    Drug Metab Dispos; 1977; 5(4):405-10. PubMed ID: 19220
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aminopyrine metabolism in primary monolayer cultures of diabetic rat hepatocytes.
    Shimeno H; Toda A; Nagamatsu A; Shigematsu H
    Xenobiotica; 1988 May; 18(5):551-60. PubMed ID: 3041683
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The kinetics of inhibition of hepatic drug metabolism by prostaglandins in rabbits.
    Weiner M
    Res Commun Chem Pathol Pharmacol; 1980 Sep; 29(3):561-71. PubMed ID: 6448462
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of experimental diabetes on hepatic drug metabolism in rats: the activities of flavin-containing monooxygenase, the phase II conjugation reactions and glutathione related enzymes.
    Toda A; Eyanagi R; Saito H; Soeda S; Shimeno H; Moriyama M; Shigematsu H
    Res Commun Mol Pathol Pharmacol; 2005; 117-118():13-27. PubMed ID: 18426076
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Altered metabolism of androstenedione by hepatic microsomes from streptozotocin-diabetic male rats.
    Reinke LA; Rosenberg H; Stohs SJ
    Res Commun Chem Pathol Pharmacol; 1978 Mar; 19(3):445-52. PubMed ID: 653101
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Purification and aminopyrine monooxygenase activity of liver microsomal cytochrome P-450 from alloxan-induced diabetic rats.
    Shimeno H; Toda A; Ogata S; Nagamatsu A
    Drug Metab Dispos; 1991; 19(2):291-7. PubMed ID: 1676625
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Altered liver function in diabetes: model experiments with aminopyrine in the rat.
    Zysset T; Tlach C
    J Pharmacol Exp Ther; 1987 Jan; 240(1):271-6. PubMed ID: 3806388
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug metabolism in spontaneously diabetic guinea pigs.
    Cook DE; Jackson JD; Past MR; Lang CM; Bullock LP
    Experientia; 1984 Aug; 40(8):840-1. PubMed ID: 6381086
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in liver gangliosides in streptozotocin-induced diabetic rats.
    Sánchez SS; Abregú AV; Aybar MJ; Sánchez Riera AN
    Cell Biol Int; 2000; 24(12):897-904. PubMed ID: 11114239
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of phenformin in normal vs. diabetic isolated perfused rat liver.
    Cook DE
    Res Commun Chem Pathol Pharmacol; 1978 Oct; 22(1):119-34. PubMed ID: 725312
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Separate influences of insulin and hyperglycemia on hepatic drug metabolism in mice with genetic and chemically induced diabetes mellitus.
    Knodell RG; Handwerger BS; Morley JE; Levine AS; Brown DM
    J Pharmacol Exp Ther; 1984 Jul; 230(1):256-62. PubMed ID: 6379147
    [TBL] [Abstract][Full Text] [Related]  

  • 15. P-Chloro-N-methylaniline demethylation by rat kidney subcellular fractions.
    Navran SS; Louis-Ferdinand RT
    Res Commun Chem Pathol Pharmacol; 1975 Dec; 12(4):713-21. PubMed ID: 1215659
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An approach measurement of the stoichiometric relationship between hepatic microsomal drug metabolism and the oxidation of reduced nicotinamide adenine dinucleotide phosphate.
    Stripp B; Zampaglione N; Hamrick M; Gillette JR
    Mol Pharmacol; 1972 Mar; 8(2):189-96. PubMed ID: 4402003
    [No Abstract]   [Full Text] [Related]  

  • 17. Inhibition of hepatic drug metabolism in VX2 carcinoma-bearing rabbits.
    Weiner M; Olson JW
    Drug Metab Dispos; 1980; 8(3):139-42. PubMed ID: 6104575
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of fleroxacin on hepatic drug metabolism in the rat.
    Grech-Bélanger O; Francoeur J; Le Bel M
    Res Commun Chem Pathol Pharmacol; 1989 Apr; 64(1):121-33. PubMed ID: 2501838
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of dietary carbohydrates (alpha-saccharides) on hepatic drug metabolism in male rats.
    Sonawane BR; Coates PM; Yaffe SJ; Koldovsky O
    Drug Nutr Interact; 1983; 2(1):7-16. PubMed ID: 6678749
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Catalytic activities of cytochrome P-450 from female rat liver: correlation with sex differences in drug metabolism in diabetic liver.
    Past MR; Cook DE
    Res Commun Chem Pathol Pharmacol; 1983 Jun; 40(3):379-90. PubMed ID: 6414061
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.